Active Cycle of Breathing Techniques on Respiratory Distress Symptom Cluster
Investigation of the Effect of Active Cycle of Breathing Techniques on Respiratory Distress Symptom Cluster in Patients With Lung Cancer
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Doğa Ulcay, Msc
- Phone Number: +905302285038
- Email: dogaulcay@maltepe.edu.tr
Study Contact Backup
- Name: Semiha Akın, Prof.
- Phone Number: +902167779317
- Email: semihaakin@sbu.edu.tr
Study Locations
-
-
-
Istanbul, Turkey
- Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Being 18 years or older
- Being diagnosed with stage IV non-small cell lung cancer
- Being diagnosed with lung cancer in the type of adenocarcinoma and squamous cell carcinoma
- Receiving outpatient chemotherapy treatment
- Receiving the first course of chemotherapy treatment
- ECOG Performance Scale Score < 3
- Having all the symptoms of dyspnea, cough, and fatigue
- Not having a cognitive disorder or a diagnosed psychiatric illness
- Being able to speak Turkish
- Volunteering to participate in the research
Exclusion Criteria:
- Experiencing a chronic obstructive pulmonary disease (COPD) exacerbation in the last 4 weeks
- Having an active lung infection
- Not volunteering to participate in the research
- Not having dyspnea, cough, and fatigue symptoms
- Not speaking Turkish
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Active Cycle Of Breathing Techniques Group
Patients in the intervention group will be provided with video-guided Active Cycle of Breathing Techniques twice a day for 28 days.
|
Patients in the intervention group will be provided with video-guided Active Cycle of Breathing Techniques twice a day for 28 days.
|
|
No Intervention: Control group
No intervention will be given to the patients in the control group.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dyspnea Level
Time Frame: 28 Days
|
The level of dyspnea will be lower in patients in the intervention (experimental) group to whom Active Breathing Cycle techniques were applied, compared to the patients in the control group who did not.
The Turkish version of the Cancer Dyspnea Scale, the Turkish Validity and Reliability of which was made by Bitek and Tokem in 2021, will be used to measure the level of dyspnea.
|
28 Days
|
|
Fatigue Level
Time Frame: 28 days
|
The level of fatigue will be lower in patients in the intervention (experimental) group to whom Active Breathing Cycle techniques were applied, compared to the patients in the control group who did not.
The Turkish version of the Hirai Cancer Fatigue Scale, the Turkish validity and reliability of which was made by Mencel in 2021, will be used to measure the level of fatigue.
|
28 days
|
|
Health-related quality of life in chronic cough
Time Frame: 28 days
|
The level of health-related quality of life in chronic cough will be lower in patients in the intervention (experimental) group to whom Active Breathing Cycle techniques were applied, compared to the patients in the control group who did not.
The Turkish version of the Leicester Cough Questionnaire (LCQ), the Turkish validity and reliability of which was made by Gonen ve Havlucu in 2014, will be used to measure the level of health-related quality of life in chronic cough.
|
28 days
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Doğa Ulcay, Msc, maltepe University
- Principal Investigator: Semiha Akın, Prof., University of Health science
- Principal Investigator: Akın Öztürk, Specialist, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- MAU_DogaUlcay_001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.